Current Opinion in Oncology

• 

  Publication Venue For

  • Do flame retardant chemicals increase the risk for thyroid dysregulation and cancer?.  29:7-13. 2017
  • Current management of adrenal tumors..  20:34-46. 2008
  • Granulocyte colony-stimulating factors: finding the right indication..  19:299-307. 2007
  • High-dose chemotherapy for breast cancer: is another look warranted?.  16:114-119. 2004
  • Allelic variations in gene expression..  16:39-43. 2004
  • Recent progress in the treatment of myelodysplastic syndrome in adult patients..  15:1-9. 2003
  • Genetic susceptibility--molecular epidemiology of head and neck cancer..  14:310-317. 2002
  • The role of surgery for patients with metastatic melanoma..  14:221-226. 2002
  • Radiation therapy in the management of rectal cancer..  13:300-306. 2001
  • Molecular pathogenesis of malignant gliomas..  11:162-167. 1999
  • Economic impact of granulopoiesis stimulating agents on the management of febrile neutropenia..  10:291-296. 1998
  • Treatment of non-Hodgkin's lymphoma with high-dose therapy and hematopoietic stem cell support..  9:420-427. 1997
  • Renal cell carcinoma..  9:301-306. 1997
  • Organ preservation in anal and rectal cancers..  8:329-333. 1996
  • High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors..  6:135-138. 1994
  • The biology of ovarian cancer..  5:900-907. 1993
  • Biology and therapy with biologic agents in gynecologic cancer..  4:946-954. 1992
  • Immunotherapy and monoclonal antibody therapies..  4:547-552. 1992
  • Unknown primary tumors..  4:3-9. 1992
  • Cellular and molecular studies in brain and nervous system oncology..  2:655-665. 1990
  • Acute leukemia in children..  2:34-40. 1990
  • Editorial Introductions.  21. 2009